Published in BMC Nephrol on May 13, 2011
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol (2014) 0.90
Fenugreek seeds reduce aluminum toxicity associated with renal failure in rats. Nutr Res Pract (2013) 0.80
Contemporary management of phosphorus retention in chronic kidney disease: a review. Clin Exp Nephrol (2015) 0.76
The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int (2017) 0.75
Phosphate binders in patients with chronic kidney disease. Aust Prescr (2017) 0.75
Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels? BMC Nephrol (2011) 0.75
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis (2003) 16.18
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med (1976) 5.10
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int (2007) 3.34
Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int (2005) 3.22
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Proc Eur Dial Transplant Assoc (1980) 1.60
Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet (1979) 1.58
Plasma aluminium: a redundant test for patients on dialysis? Ann Clin Biochem (2005) 1.51
Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients. Perit Dial Int (2006) 1.42
Letter: Aluminum and dialysis dementia. Lancet (1976) 1.36
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.10
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant (2006) 1.03
Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int (1989) 1.02
Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Am J Med Sci (1989) 0.99
Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis (2005) 0.98
Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. Am J Kidney Dis (1999) 0.92
Encephalopathy in infants and children with chronic renal disease. Arch Neurol (1981) 0.89
Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med (1984) 0.87
Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. ASAIO Trans (1987) 0.83
Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci (1992) 0.83
Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton) (2007) 0.83
Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat. J Lab Clin Med (1989) 0.82
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Clin Nephrol (1996) 0.81
Aluminum removal by hemodialysis. Kidney Int (1981) 0.80
An evaluation of a new and effective phosphorus binding agent. Trans Am Soc Artif Intern Organs (1973) 0.78
Aluminium absorption and antacid therapy in infancy. J Paediatr Child Health (1992) 0.78
Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients. Nephrol Dial Transplant (1997) 0.77
[Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era]. Nefrologia (2008) 0.77
Aluminium-related osteomalacia: response to reverse osmosis water treatment. Kidney Int (1987) 0.77
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics (2014) 3.52
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
The effect of obesity on renal transplant outcomes. Transplantation (2002) 2.29
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Transplantation (2002) 1.98
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int (2002) 1.84
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81
Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2013) 1.77
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int (2013) 1.75
Clinical practice guidelines for peritoneal access. Perit Dial Int (2010) 1.71
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69
Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant (2009) 1.68
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int (2009) 1.66
Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev (2014) 1.63
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) (2012) 1.61
Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2009) 1.61
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. Ann Emerg Med (2005) 1.60
Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Perit Dial Int (2007) 1.59
Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev (2009) 1.58
Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant (2004) 1.56
Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int (2011) 1.56
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev (2014) 1.52
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.52
The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation (2004) 1.52
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant (2007) 1.51
Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int (2009) 1.49
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47
The frequency of complications associated with the use of multiple-dose activated charcoal. Ann Emerg Med (2003) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Practice variations in the treatment of febrile infants among pediatric emergency physicians. Pediatrics (2009) 1.45
Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int (2010) 1.45
Nebulized epinephrine for croup in children. Cochrane Database Syst Rev (2011) 1.43
Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) (2005) 1.43
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol (2003) 1.41
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Patient management by cyclosporine C2 monitoring: not enough science yet to justify the practice. Transplantation (2003) 1.38
Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2004) 1.38
Croup in the paediatric emergency department. Paediatr Child Health (2007) 1.38
Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol (2005) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol (2013) 1.36
Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol Dial Transplant (2008) 1.35
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int (2009) 1.34
Review article: Hepatitis B and dialysis. Nephrology (Carlton) (2010) 1.32
Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol (2009) 1.31
Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis (2010) 1.31
Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol (2009) 1.30
Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol (2012) 1.30
Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) (2007) 1.28
The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant (2008) 1.27
Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int (2003) 1.26